Immune CPIs as Mono and Combination Therapy for RCC: New 1L Strategies + ESMO Updated Guidelines, Clinical & Biological Drivers for Treatment Decisions
By
CECOG Academy
FEATURING
Manuela Schmidinger
By
CECOG Academy
FEATURING
Manuela Schmidinger
Comments 1
Login to view comments.
Click here to Login
